Golden State Wealth Management, LLC Novo Cure LTD Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 3 shares of NVCR stock, worth $68. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$68% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
76.7MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$278 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$272 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$182 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$98.8 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$69.5 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.41B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...